FBXO17
F-box only protein 17
Also known as: FBG4, Fbx17, FBX17_HUMAN, FBXO26, FLJ11798, FLJ25205, MGC9379
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96EF6
- Gene
- FBXO17
- Ensembl
- ENSG00000269190
- Chromosome
- 19
- Canonical length
- 278 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the F-box protein family which is characterized by the F-box motif. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class and it contains an F-box domain. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
278 residues, UniProt reviewed canonical sequence.
>Q96EF6|FBXO17
1 MGARLSRRRL PADPSLALDA LPPELLVQVL SHVPPRSLVT RCRPVCRAWR DIVDGPTVWL
61 LQLARDRSAE GRALYAVAQR CLPSNEDKEE FPLCALARYC LRAPFGRNLI FNSCGEQGFR
121 GWEVEHGGNG WAIEKNLTPV PGAPSQTCFV TSFEWCSKRQ LVDLVMEGVW QELLDSAQIE
181 ICVADWWGAR ENCGCVYQLR VRLLDVYEKE VVKFSASPDP VLQWTERGCR QVSHVFTNFG
241 KGIRYVSFEQ YGRDVSSWVG HYGALVTHSS VRVRIRLSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FBXO17 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 71 nTPM
Expression across tissuesHPA
Tissue
- liver: 71 nTPM
- kidney: 44 nTPM
- ovary: 35 nTPM
- cervix: 31 nTPM
- endometrium: 27 nTPM
- cerebellum: 25 nTPM
Single-cell type
- proximal tubule cells: 113 nCPM
- distal convoluted tubule cells: 98 nCPM
- renal connecting tubule cells: 96 nCPM
- loop of henle epithelial cells: 89 nCPM
- podocytes: 81 nCPM
- renal collecting duct intercalated cells: 63 nCPM
Immune cell
- neutrophil: 0.6 nTPM
- memory B-cell: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- cerebellum: 15 nTPM
- amygdala: 10 nTPM
- hypothalamus: 10 nTPM
- cerebral cortex: 9.7 nTPM
- basal ganglia: 8.5 nTPM
- hippocampal formation: 8.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.77
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.21
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ERAD pathway
- glycoprotein catabolic process
- SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FBXO17 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FBXO17 as an antibody target. Whether an autoantibody or antibody against FBXO17 could matter depends on whether native FBXO17 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FBXO17 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FBXO17 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...